Skip to content
★ Sign in to follow
JB

Johannes Bacher

Executive
Chief Executive Officer
Opgen Inc
Total declarations
10
Company
1
▲ Purchases (6 ops.)
€83k
▼ Sales (0 ops.)
—

Latest filing published 31 Mar 2023 for OPGEN INC.

Filing timeline

BuySale
Johannes Bacher

Insider track record

Disclosed buys
6
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Johannes Bacher: trading record in brief

Johannes Bacher (chief executive) discloses dealings in CapForce Inc. to SEC (Form 4). The record holds 10 filings, for trades running from 10 June 2021 to 31 March 2023.

Every open-market trade on record is a purchase: 6 purchases worth €83k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 option exercises.

Half of the purchases are above €16k and half below. On 5 out of 6 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 31 March 2023 with an option exercise in CapForce Inc. The last purchase on record was published on 27 January 2022, which is 1,746 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Johannes Bacher

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◇
    Chief Operating OfficerExecutivesOpgen Inc
    0SEC
    6,434 shares0Common StockSEC:0001079973-23-000409:0
  • ◇
    Chief Operating OfficerExecutivesOpgen Inc
    0SEC
    1,125 shares0Common StockSEC:0001079973-23-000288:0
  • ◇
    Chief Operating OfficerExecutivesOpgen Inc
    0SEC
    21,250 shares0Common StockSEC:0001079973-22-000215:0
  • ▲
    Chief Operating OfficerExecutivesOpgen Inc
    21,250 USD24SEC
    25,000 shares@ US$0.8529.5% of flowCommon StockSEC:0001079973-22-000102:0
    Canonical exit: 26 Apr 2022 (T+90)
  • ▲
    Chief Operating OfficerExecutivesOpgen Inc
    15,347 USD33SEC
    10,000 shares@ US$1.534721.2% of flowComon StockSEC:0001553350-21-001073:0
    Canonical exit: 17 Feb 2022 (T+90)
  • ▲
    Chief Operating OfficerExecutivesOpgen Inc
    15,350 USD31SEC
    5,000 shares@ US$3.0720.4% of flowCommon StockSEC:0001079973-21-000919:0
    Canonical exit: 14 Dec 2021 (T+90)
  • ▲
    Chief Operating OfficerExecutivesOpgen Inc
    22,500 USD30SEC
    10,000 shares@ US$2.2529.0% of flowCommon StockSEC:0001079973-21-000522:0
    Canonical exit: 8 Sept 2021 (T+90)

7 of 7 declarations